Rallybio RLYB
NASDAQ RLYB
$16.83 +0.23 (+1.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Rallybio (RLYB) Cash from Financing Activities (2020 - 2026)

Rallybio (RLYB) posted Cash from Financing Activities of $3000.0 for Q1 2026, down 50.0% sequentially from $6000.0 in Q4 2025.

Rallybio (RLYB) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Rallybio has reported Cash from Financing Activities for 7 years, with the latest figure at $3000.0 in Q1 2026.

  • Quarterly Cash from Financing Activities changed N/A year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19000.0 (down 99.63% YoY) and the FY2025 annual result came in at $16000.0, down 99.69% from the prior year.
  • Cash from Financing Activities eased to $3000.0 in Q1 2026 per RLYB's latest filing, from $6000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $51.2 million in Q4 2022 and troughed at -$139000.0 in Q1 2023.
  • A 5-year average of $5.1 million and a median of $10000.0 in 2025 frame the typical range for Cash from Financing Activities.
  • The widest YoY moves for Cash from Financing Activities: up 3255.89% in 2022, down 100.09% in 2022.
  • Over 5 years, Cash from Financing Activities stood at $51.2 million in 2022, then tumbled by 99.86% to $72000.0 in 2023, then slumped by 75.0% to $18000.0 in 2024, then slumped by 66.67% to $6000.0 in 2025, then slumped by 50.0% to $3000.0 in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $3000.0, $6000.0, and $10000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 Rallybio 94.61 Mn 94.61 Mn - 131,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 131,000.00
Jun 30, 2026 131,000.00
Mar 31, 2026 3,000.00
Mar 31, 2026 3,000.00
Dec 31, 2025 6,000.00
Dec 31, 2025 6,000.00
Jun 30, 2025 10,000.00
Jun 30, 2025 10,000.00
Dec 31, 2024 18,000.00
Dec 31, 2024 18,000.00
Sep 30, 2024 -11,000.00
Sep 30, 2024 -11,000.00
Jun 30, 2024 5.19 Mn
Jun 30, 2024 5.19 Mn
Dec 31, 2023 72,000.00
Dec 31, 2023 72,000.00
Jun 30, 2023 210,000.00
Jun 30, 2023 210,000.00
Mar 31, 2023 -139,000.00
Mar 31, 2023 -139,000.00